Literature DB >> 10609591

The social determinants of emergency department and hospital use by injection drug users in Canada.

A Palepu1, S A Strathdee, R S Hogg, A H Anis, S Rae, P G Cornelisse, D M Patrick, M V O'Shaughnessy, M T Schechter.   

Abstract

OBJECTIVE: The aim of this study was to describe the relationship between sociodemographic characteristics and human immunodeficiency (HIV) status of a cohort of injection drug users (IDUs) on their self-reported health service utilization.
DESIGN: Interviewer-administered questionnaire.
METHODS: IDUs who had injected illicit drugs within the previous month were recruited through street outreach. They underwent serology for HIV-1 and questionnaires on demographics, drug using behaviors, housing status, and health service utilization (hospitalization overnight and emergency department visits) in the previous 6 months. Logistic regression analysis was used to identify independent associations with the use of health services.
RESULTS: Of 1,103 cohort participants, 65% were male, 63% were white, and 23% were HIV positive. Cocaine was the most frequently injected drug used. Almost half (47%) had used health services in the previous 6 months. The following variables were associated independently with health service utilization (adjusted odds ratio; 95% confidence interval): unstable housing, defined as living primarily in a hotel, boarding room, or transition house or on the street in the past 6 months (1.44; 1.11-1.86); female gender (1.45; 1.11-1.89); HIV-positive status (1.43; 1.06-1.92); injection of cocaine (1.50; 1.12-2.02); and primary care I physician visit in past 6 months (1.91; 1.39-2.64).
CONCLUSION: IDUs with unstable housing were more likely to report emergency department and hospital use, which may be a reflection of their disorganized lifestyle or poorer health status. Further studies are required to assess the effect on the health status and health care use of IDUs of interventions that increase the availability of safe, affordable housing.

Entities:  

Mesh:

Year:  1999        PMID: 10609591      PMCID: PMC3456690          DOI: 10.1007/BF02351499

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  22 in total

1.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study.

Authors:  S A Strathdee; D M Patrick; S L Currie; P G Cornelisse; M L Rekart; J S Montaner; M T Schechter; M V O'Shaughnessy
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

2.  Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users.

Authors:  C Hartgers; E J van Ameijden; J A van den Hoek; R A Coutinho
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

3.  Variation in health service use among HIV-infected patients.

Authors:  V Mor; J A Fleishman; M Dresser; J Piette
Journal:  Med Care       Date:  1992-01       Impact factor: 2.983

4.  Has the United Kingdom averted an epidemic of HIV-1 infection among drug injectors?

Authors:  G V Stimson
Journal:  Addiction       Date:  1996-08       Impact factor: 6.526

Review 5.  Can HIV epidemics among injection drug users be prevented?

Authors:  S A Strathdee; E J van Ameijden; F Mesquita; A Wodak; S Rana; D Vlahov
Journal:  AIDS       Date:  1998       Impact factor: 4.177

6.  Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver.

Authors:  D M Patrick; S A Strathdee; C P Archibald; M Ofner; K J Craib; P G Cornelisse; M T Schechter; M L Rekart; M V O'Shaughnessy
Journal:  Int J STD AIDS       Date:  1997-07       Impact factor: 1.359

7.  Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS).

Authors:  L Solomon; M Stein; C Flynn; P Schuman; E Schoenbaum; J Moore; S Holmberg; N M Graham
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-03-01

Review 8.  Injection drug use and human immunodeficiency virus infection.

Authors:  P Alcabes; G Friedland
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

9.  Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.

Authors:  L Solomon; R Frank; D Vlahov; J Astemborski
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

10.  Differences in mortality rates and causes of death between HIV positive and HIV negative intravenous drug users.

Authors:  A Eskild; P Magnus; S O Samuelsen; C Sohlberg; P Kittelsen
Journal:  Int J Epidemiol       Date:  1993-04       Impact factor: 7.196

View more
  39 in total

Review 1.  Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration.

Authors:  Sandro Galea; David Vlahov
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

2.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

3.  Crack use as a public health problem in Canada: call for an evaluation of 'safer crack use kits'.

Authors:  Emma Haydon; Benedikt Fischer
Journal:  Can J Public Health       Date:  2005 May-Jun

4.  Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence.

Authors:  Ryan Schwarz; Alexei Zelenev; R Douglas Bruce; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2012-04-24

5.  The impact of unstable housing on emergency department use in a cohort of HIV-positive people in a Canadian setting.

Authors:  Surita Parashar; Keith Chan; David Milan; Eric Grafstein; Alexis K Palmer; Chelsey Rhodes; Julio S G Montaner; Robert S Hogg
Journal:  AIDS Care       Date:  2013-05-08

6.  Role of primary care providers in hepatitis C prevention and care: one step away from evidence-based practice.

Authors:  Andreea Adelina Artenie; Julie Bruneau; Annie Lévesque; Jean-Marie Bamvita Wansuanganyi
Journal:  Can Fam Physician       Date:  2014-10       Impact factor: 3.275

7.  Non-disclosure of drug use in outpatient health care settings: Findings from a prospective cohort study in Vancouver, Canada.

Authors:  Lindsay A Pearce; Fahmida Homayra; Laura M Dale; Soroush Moallef; Brittany Barker; Alexa Norton; Kanna Hayashi; Bohdan Nosyk
Journal:  Int J Drug Policy       Date:  2020-07-27

8.  Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study.

Authors:  Elisa Lloyd-Smith; Evan Wood; Ruth Zhang; Mark W Tyndall; Sam Sheps; Julio S G Montaner; Thomas Kerr
Journal:  BMC Public Health       Date:  2010-06-09       Impact factor: 3.295

9.  Addiction treatment and stable housing among a cohort of injection drug users.

Authors:  Anita Palepu; Brandon D L Marshall; Calvin Lai; Evan Wood; Thomas Kerr
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

10.  Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting.

Authors:  Christina Kim; Thomas Kerr; Kathy Li; Ruth Zhang; Mark W Tyndall; Julio S G Montaner; Evan Wood
Journal:  BMC Public Health       Date:  2009-07-29       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.